Completed PHASE2 INTERVENTIONAL 2-arm NCT01601366

LNG-IUS for Treatment of Dysmenorrhea (LNGIUSAD)

Levonorgestrel-releasing Intrauterine System Compared to Low Dose Combined Oral Contraceptive Pills for Treatment of Adenomyosis: a Randomized Controlled Trial

Sponsor: Omar Mamdouh Shaaban

Conditions Adenomyosis

Interventions Combined oral contraceptives LNG-IUS

Updated 6 times since 2017 Last updated: Nov 20, 2017 Started: Apr 30, 2012 Primary completion: Apr 30, 2013 Completion: Apr 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01601366, this PHASE2 trial focuses on Adenomyosis and remains completed. Sponsored by Omar Mamdouh Shaaban, it has been updated 6 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Dec 2017 — Jun 2018 [monthly]

Completed PHASE2

Status: Unknown Status → Completed

▶ Show 1 earlier version

Jan 2017 — Dec 2017 [monthly]

Unknown Status PHASE2

First recorded

Apr 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Omar Mamdouh Shaaban

Data source: Assiut University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.